loading page

Ventricular Arrhythmia Burden and Relationship to Interdialytic Period in Dialysis Patients with Cardiac Devices
  • +5
  • Evan Harmon,
  • Brittney Heard,
  • Sarah Ratcliffe,
  • Mark Smolkin,
  • J Michael Mangrum,
  • Sula Mazimba,
  • Brendan Bowman,
  • Nishaki Mehta
Evan Harmon
University of Virginia Health System

Corresponding Author:[email protected]

Author Profile
Brittney Heard
University of Virginia Health System
Author Profile
Sarah Ratcliffe
University of Virginia Health System
Author Profile
Mark Smolkin
University of Virginia Health System
Author Profile
J Michael Mangrum
University of Virginia Health System
Author Profile
Sula Mazimba
University of Virginia Health System
Author Profile
Brendan Bowman
University of Virginia Health System
Author Profile
Nishaki Mehta
William Beaumont Hospital - Royal Oak
Author Profile

Abstract

Background: Sudden cardiac death (SCD) is a major driver of mortality in patients with end-stage renal disease (ESRD) on hemodialysis (HD). The degree to which ventricular arrhythmias (VA) play a role in SCD in ESRD patients is unclear. Objective: Use cardiac implantable electronic devices (CIEDs) to clarify VA burden in ESRD patients overall and in relation to interdialytic cycle. Methods: We identified 44 patients at a single academic center with CIEDs, 22 on HD, along with 22 age- and sex-matched controls. Device interrogations from 11/13/14 – 4/8/19 were reviewed. Results: Overall, there were no differences in HD patients and controls in adjusted overall event rate (HD 9.81 x 10-5 ± 1.5 x 10-3 events/patient-hours vs control 3.71 x 10-5 ± 9.1 x 10-4 events/patient-hours, p = 0.902), or proportion of patients experiencing VA event (HD 45.4% vs control 63.6%, p = 0.226). There was no difference in ventricular pacing burden. Controls were more likely to require device therapy for VT/VF episodes (total ATP episodes 2/38 in HD vs 10/22 in controls, p < 0.01, total ICD shocks 10/38 in HD vs 17/22 in controls, p < 0.01). HD patients were most likely to experience VA within 12-hours of HD completion (p < 0.01), and the vast majority of events were NSVT. Conclusion: VA and ventricular pacing burden was similar by CIED analysis between groups. In HD patients, VA were likely to occur within the first 12 hours post-dialysis, were primarily NSVT, and were unlikely to require device therapy.